September 23, 2022
In our news update a few months ago we told you about cystic fibrosis, a rare disease that is one of the areas of expertise of our experienced medical and scientific writing team. In particular, we have already helped our clients with a range of projects on this topic, including:
The “Virades de l’espoir”, walks of hope to help in the fight against cystic fibrosis organized by the association Vaincre la Mucoviscidose in France, provide a timely opportunity to focus on this disease. Similar events take place in many countries around the world, including the Great Strides™ walking challenges organized by the Cystic Fibrosis Trust in the UK and the Cystic Fibrosis Foundation in the US.
Read moreSeptember 21, 2022
Alzheimer’s disease is a major global healthcare challenge. The number of people living with Alzheimer’s disease or other forms of dementia is currently estimated at over 55 million worldwide, and this number is expected to reach 78 million by 2030. The prevalence of dementia is estimated at around 10 million across all European countries, and is expected to almost double by 2050. In France, 2.2 million people may be affected by the disease by 2050.
Associations and foundations around the world, including Alzheimer’s disease international, the UK Alzheimer’s society, and the French Fondation Vaincre Alzheimer and the France Alzheimer association, organize events every year to raise awareness about the disease, and fight prejudice against those living with Alzheimer’s by highlighting the preserved abilities of those affected by the disease and encouraging the general public to see the disease in a new light.
This year, World Alzheimer’s Day is on September 21, 2022. As part of the theme, “Know dementia, Know Alzheimer’s”, we invite you to take another look at the impact of this neurodegenerative disease on the different types of memory: not all types of memory are affected in the same way by the disease, and some memories are relatively well preserved.
Read moreSeptember 13, 2022
Synergy Pharm keeps you informed about medication safety, the theme chosen by the World Health Organization (WHO) for the 2022 edition of World Patient Safety Day.
Read moreJuly 21, 2022
Synergy Pharm USA can support you from A to Z with the publication of your peer-reviewed journal supplement. We can produce your supplement from conference presentations or your study results. At our health communication agency, several scientific or medical articles can be written in parallel by our medical writers, which allows the rapid publication of the supplement after the event. Our editorial assistance and medical writing team can help to coordinate your project, reducing the delays associated with author proofreading, article review, submission and publication.
Read moreMay 19, 2022
On 26 May 2022, Regulation (EU) 2017/746 will come into force for in vitro diagnostic medical devices (IVDMDs). Full details of this new regulation (IVDR) are available at: https://eur-lex.europa.eu/eli/reg/2017/746/oj
Read moreApril 18, 2022
April 18 is European Patients’ Rights Day (EPRD).
The European Charter of Patients’ Rights proclaims 14 rights that aim to guarantee “a high level of protection of human health” and to ensure the provision of high quality of health services in European countries, in particular during the Covid pandemic.
Read moreMarch 14, 2022
On the occasion of the national “Week Against Cancer” campaign in France, it is important to highlight research efforts aimed at reducing the side effects associated with cancer treatments.
Indeed, while the range of treatments available – used alone or in combination – are effective against cancer, they can have many side effects, particularly on the skin. Xerosis is one of the most frequent side effects of cancer therapy and requires appropriate management to help maintain patient quality of life and prevent potential interruptions to cancer treatment.
Read moreMarch 9, 2022
Next week (14th – 20th of March) is the 24th Brain Awareness Week (BAW), “a global campaign to foster public enthusiasm and support for brain science” (https://www.brainawareness.org/about/).
There are many events taking place across the world, and several activities are also being proposed to help you get involved in the campaign.
In France, the “Société des Neurosciences” is hosting an extensive program, with replays of a range of conferences also being made available.
Many of the topics covered are related to themes* that our medical writing team has addressed in the form of articles and/or sketchnotes for the general public in collaboration with the “Observatoire B2V des Mémoires” (B2V Memory Observatory): https://www.synpharm.com/en/sketchnote/
*Learning, Brain and Artificial Intelligence, Brain and New Technologies, Brain and Society, Brain and Sport, Sleep, The 5 senses, Emotions, Memory, The Sick Brain.
February 28, 2022
By definition, a rare disease has a prevalence of 1/2,000. But rare diseases are numerous and would affect more than 3 million people in France, more than 300 million in the world!
Most of these diseases have no treatment. Nevertheless, many actors are mobilized in the fight against rare diseases to improve the diagnosis, care and follow-up of the patients concerned; research in this area also allows significant medical advances.
In 2021, we again had the opportunity to put our medical writing skills at the service of several rare diseases, including craniofacial microsomia, cystic fibrosis, and inherited epidermolysis bullosa.
Read moreJanuary 25, 2022
Synergy Pharm feels particularly concerned about Neglected Tropical Diseases (NTDs) and keeps you informed about the activities of the WHO.
On Sunday 30 January 2022, the WHO will celebrate the World Neglected Tropical Diseases Day (WNTDD). The WHO activities aim to mobilize the world to defeat NTD (https://www.who.int/campaigns/world-ntd-day/world-ntd-day-2022).
Read more